Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccine
about
Anti-idiotypic antibodies as cancer vaccines: achievements and future improvementsRacotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides - preclinical and clinical dataAnti-idiotypic antibodies: a new approach in prion research.Strategies for mimicking Neisserial saccharide epitopes as vaccines.Studies using the anti-idiotypic monoclonal antibody 105AD7 in patients with primary and advanced colorectal cancer.Prospects for colorectal cancer treatment: oral chemotherapy and targeted biotherapy.Yeast whole glucan particle (WGP) beta-glucan in conjunction with antitumour monoclonal antibodies to treat cancer.Development of the PANVAC-VF vaccine for pancreatic cancer.Role of T-cell epitope-based vaccine in prophylactic and therapeutic applications.Monoclonal antibodies for cancer immunotherapy.Combined yeast-derived beta-glucan with anti-tumor monoclonal antibody for cancer immunotherapy.Carcinoembryonic antigen as a vaccine target.Preventive DNA vaccination against CEA-expressing tumors with anti-idiotypic scFv6.C4 DNA in CEA-expressing transgenic mice.Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen.Agonist peptide from a cytotoxic t-lymphocyte epitope of human carcinoembryonic antigen stimulates production of tc1-type cytokines and increases tyrosine phosphorylation more efficiently than cognate peptide.Colorectal cancer vaccines.Functional mimicry of an anti-idiotypic antibody to nominal antigen on cellular response.
P2860
Q28278814-D16211D1-3379-4AC0-8C38-ACAA6D49DCE7Q30575331-092124D7-5004-4788-8D3D-2EED373D9FF0Q33419724-C11B056A-788A-4088-A319-8118CE7ADE3CQ34552298-D6F457DF-1B1F-432E-87A6-558E4965137CQ34979517-BB53289E-6C68-44EF-AB06-40FE131BFF44Q35204961-D4055092-3401-4385-BC02-134BB5F98974Q36150511-056C6435-C663-4EBF-A242-77A3BF39EC07Q36383786-4F3C8481-B970-43D4-ADB3-4F4723688432Q36795668-5CA8D5A5-B1F2-4D29-A9BF-8B69EE4FD022Q37181031-E9B50577-26E2-4973-BECD-AD4068810CB6Q37201291-EF221544-4EF2-4DBC-861D-59897C08EE7EQ37259606-52B034ED-1B7D-4FAB-922A-55A414E72372Q38727803-43D77E16-9C19-4FBA-A43D-3D812E61C562Q40245988-AF3D723F-EDA0-4962-A25D-1393C18A1AFAQ40894906-231E7596-6479-40DF-ADEA-74960E5339B1Q41720736-A14ED93C-4186-4848-9E4A-9E49F961C61FQ55044203-FDBA6756-ABA2-4AD0-84EA-0C8693045B8B
P2860
Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccine
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Immune response to the carcino ...... anti-idiotype antibody vaccine
@ast
Immune response to the carcino ...... anti-idiotype antibody vaccine
@en
type
label
Immune response to the carcino ...... anti-idiotype antibody vaccine
@ast
Immune response to the carcino ...... anti-idiotype antibody vaccine
@en
prefLabel
Immune response to the carcino ...... anti-idiotype antibody vaccine
@ast
Immune response to the carcino ...... anti-idiotype antibody vaccine
@en
P2093
P2860
P356
P1476
Immune response to the carcino ...... anti-idiotype antibody vaccine
@en
P2093
A Sherratt
M Bhattacharya-Chatterjee
M Chakraborty
P2860
P304
P356
10.1172/JCI118039
P407
P577
1995-07-01T00:00:00Z